L’Oréal set to invest USD 80M in Mexico to expand production
This move demonstrates L’Oréal’s forward-looking approach to strengthening its manufacturing footprint in Mexico and supporting its global supply chain development.
USA – L’Oréal is set to invest over USD 80 million in Mexico by 2026 to expand its production capacity.
According to L’Oréal, this investment will focus on expanding production lines at its plants located in San Luis Potosí and Mexico City.
The expansion aims to support the growing demand for L’Oréal’s products in the region and strengthen its manufacturing capabilities in the Mexican market.
This move is part of L’Oréal’s broader strategy to boost its presence and production in key emerging markets, reflecting the company’s ongoing commitment to growth and innovation in the beauty and personal care sector.
The investment highlights L’Oréal’s confidence in Mexico as a strategic hub for production and distribution in Latin America, aligning with the increasing demand for beauty products in the region.
This substantial capital injection will help L’Oréal enhance its operational efficiency and meet the rising consumer demand, positioning the company firmly for future market growth in Mexico and adjacent markets.
The expansion through 2026 demonstrates L’Oréal’s forward-looking approach to strengthening its manufacturing footprint in Mexico and supporting its global supply chain development.
L’Oréal’s decision comes at a time when the American beauty industry is experiencing rapid growth, fueled by changing consumer preferences and rising disposable incomes.
According to a report by Mordor Intelligence, the American beauty and personal care products market is valued at USD 130.25 billion in 2025 and is projected to reach USD 154.35 billion by 2030, growing at a CAGR of 3.45%.
This move comes after L’Oréal Groupe recently revealed its move to acquire a majority stake in the British skincare brand Medik8, solidifying its expansion into the premium skincare market.
The newly signed agreement underscores L’Oréal’s strategic focus on innovative and high-performance beauty solutions.
However, Inflexion, a prominent European mid-market private equity firm, which acquired Medik8 in 2021, will retain a minority stake in the company as part of the transaction, ensuring its continued involvement in the company’s future development.
In addition, Elliot Isaacs, the founder of Medik8, will retain his position on the board, while the existing management committee will stay in place to maintain operational stability and continuity.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
